• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

    Page 17 of 100

  • Healthcare jobs reportHealth

    There’s been a strange fluctuation in the health care job market during the pandemic

    By Sy Mukherjee
  • AstraZeneca Gilead dealHealth

    Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense

    By Sy Mukherjee
  • Black lives coronavirusNewsletters

    The health care system is stacked against black lives

    By Sy Mukherjee
  • Kenneth Frazier of Merck (left), Severin Schwan of Roche (center), Alex Gorsky of Johnson & Johnson (right).Health

    5 companies to keep an eye on following the world’s largest cancer conference

    By Sy Mukherjee
  • Coronavirus reopen nuancesNewsletters

    Getting back to the office in the midst of coronavirus is going to be complicated

    By Sy Mukherjee
  • CDC COVID-19 antibody test guidanceHealth

    The CDC says antibody tests shouldn’t be used to make return-to-work decisions

    By Sy Mukherjee
  • Moderna Therapeutics coronavirus vaccineNewsletters

    Moderna’s coronavirus vaccine expectations game

    By Sy Mukherjee
  • Outside the Elmhurst Hospital Center in New York City on April 25, 2020.Health

    The health care industry’s winners and losers in the midst of the pandemic

    By Sy Mukherjee
  • MOSCOW, RUSSIA – MAY 12, 2020: A person holds a cigarette. Moscow Mayor Sergei Sobyanin made mandatory wearing face masks and gloves for public transport and taxi passengers as well as shoppers since May 12. Valery Sharifulin/TASS (Photo by Valery SharifulinTASS via Getty Images)Health

    Tobacco giants are getting into the coronavirus vaccine race

    By Sy Mukherjee
  • Moderna coronavirus vaccine trialHealth

    Moderna releases promising—but early—new coronavirus vaccine data

    By Sy Mukherjee
  • Roche antibody test ElecsysNewsletters

    Antibody testing’s chicken and egg problem

    By Sy Mukherjee
  • U.S. Speaker of the House Rep. Nancy Pelosi (D-CA) speaks during a weekly news conference at the U.S. Capitol May 7, 2020 in Washington, DC.Politics

    4 takeaways from the House Democrats’ new $3 trillion stimulus bill

    By Nicole Goodkind and Sy Mukherjee
  • A health worker handles a blood sample on the first day of a free COVID-19 antibody testing event at the Volusia County Fairgrounds.Health

    Antibody testing will be key—once we understand what the results mean

    By Sy Mukherjee
  • Gilead remdesivir priceNewsletters

    Gilead’s moral (and financial) COVID-19 conundrum

    By Sy Mukherjee
  • Gilead-Sciences-RemdesivirHealth

    Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?

    By Sy Mukherjee
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.